OstomyCure

OstomyCure

Oslo, Norway· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

OstomySecure is a clinical-stage medical device innovator focused on transforming care for ostomy patients. Its flagship product, the TIES® System, is a three-component implantable device that aims to provide a continent, controlled stoma management solution, eliminating the need for a permanent external pouch. The technology is currently under clinical investigation across multiple European countries and India, positioning the company to address a significant unmet need in the global stoma care market. OstomySecure operates as a private, pre-revenue entity, advancing its platform through clinical trials.

GastroenterologyOncologySurgery

Technology Platform

The TIES® (Transcutaneous Implant Evacuation System) is a three-component implantable medical device platform. It consists of a surgically implanted abdominal port that integrates with tissue, a removable external sealing lid, and a dedicated emptying pouch. The platform enables controlled, continent stoma management without a permanent external ostomy bag.

Opportunities

The global ostomy care market is large and ripe for disruption by a solution that improves quality of life and reduces long-term consumable costs.
Successful clinical data could position OstomySecure for acquisition by a major medtech company or as a standalone leader in a new therapeutic device category.

Risk Factors

Major risks include failure to demonstrate sufficient safety and efficacy in ongoing clinical trials, leading to regulatory rejection.
Even if approved, the company faces challenges in achieving surgeon adoption, securing favorable reimbursement, and competing against large, established ostomy care companies.

Competitive Landscape

Primary competition comes from large, entrenched manufacturers of traditional ostomy pouches and accessories (e.g., Coloplast, ConvaTec, Hollister). The TIES System is a disruptive, implant-based technology that does not have a direct equivalent, but incumbents have significant resources to develop or acquire competing solutions if the market validates the approach.